33 related articles for article (PubMed ID: 38488091)
21. Diagnosis and treatment of clinically amyopathic dermatomyositis (CADM): a case series and literature review.
Gil B; Merav L; Pnina L; Chagai G
Clin Rheumatol; 2016 Aug; 35(8):2125-2130. PubMed ID: 25846833
[TBL] [Abstract][Full Text] [Related]
22. Utility of anti-melanoma differentiation-associated gene 5 antibody measurement in identifying patients with dermatomyositis and a high risk for developing rapidly progressive interstitial lung disease: a review of the literature and a meta-analysis.
Chen Z; Cao M; Plana MN; Liang J; Cai H; Kuwana M; Sun L
Arthritis Care Res (Hoboken); 2013 Aug; 65(8):1316-24. PubMed ID: 23908005
[TBL] [Abstract][Full Text] [Related]
23. Anti-MDA5 Antibody Spectrum in Western World.
Moghadam-Kia S; Oddis CV; Aggarwal R
Curr Rheumatol Rep; 2018 Oct; 20(12):78. PubMed ID: 30382445
[TBL] [Abstract][Full Text] [Related]
24. Hypomyopathic dermatomyositis associated with interstitial lung disease and good response to mycophenolate mofetil: case-based review.
Koyama RVL; Braga TKK; da Silva Dias GA; Fujihara S; Fuzii HT; Yoshikawa GT
Clin Rheumatol; 2017 Aug; 36(8):1919-1926. PubMed ID: 28488124
[TBL] [Abstract][Full Text] [Related]
25. Clinical spectrum and therapeutics in Canadian patients with anti-melanoma differentiation-associated gene 5 (MDA5)-positive dermatomyositis: a case-based review.
Huang K; Vinik O; Shojania K; Yeung J; Shupak R; Nimmo M; Avina-Zubieta JA
Rheumatol Int; 2019 Nov; 39(11):1971-1981. PubMed ID: 31375890
[TBL] [Abstract][Full Text] [Related]
26. A Japanese-American female with rapidly progressive interstitial lung disease associated with clinically amyopathic dermatomyositis.
Takada T; Asakawa K; Barrios R
Clin Rheumatol; 2021 Mar; 40(3):1159-1165. PubMed ID: 32676922
[TBL] [Abstract][Full Text] [Related]
27. Cardiac involvement in anti-MDA5 dermatomyositis: a case-based review.
Quintero-González DC; Navarro-Beleño K; López-Gutiérrez LV; Muñoz-Urbano M; Vanegas-García AL; Muñoz-Vahos CH
Clin Rheumatol; 2023 Mar; 42(3):949-958. PubMed ID: 36454342
[TBL] [Abstract][Full Text] [Related]
28. Amyopathic dermatomyositis may be on the spectrum of autoinflammatory disease: A clinical review.
Sharmeen S; Christopher-Stine L; Salvemini JN; Gorevic P; Clark R; Yao Q
Rheumatol Immunol Res; 2024 Mar; 5(1):42-48. PubMed ID: 38571935
[TBL] [Abstract][Full Text] [Related]
29. Clinical, histologic and prognostic features of clinically amyopathic dermatomyositis.
Fornaro M; Girolamo F; Giannini M; Coladonato L; Capuano A; Capodiferro M; D'Abbicco D; Ruggieri M; Mastrapasqua M; Iannone F
Clin Exp Rheumatol; 2024 Feb; 42(2):288-294. PubMed ID: 38488091
[TBL] [Abstract][Full Text] [Related]
30. A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies.
Gerami P; Schope JM; McDonald L; Walling HW; Sontheimer RD
J Am Acad Dermatol; 2006 Apr; 54(4):597-613. PubMed ID: 16546580
[TBL] [Abstract][Full Text] [Related]
31. MDA5 autoantibody-another indicator of clinical diversity in dermatomyositis.
Sontheimer RD
Ann Transl Med; 2017 Apr; 5(7):160. PubMed ID: 28480196
[TBL] [Abstract][Full Text] [Related]
32. Rapidly progressive interstitial lung disease due to anti-MDA5 antibodies without skin involvement: a case report and literature review.
González-Moreno J; Raya-Cruz M; Losada-Lopez I; Cacheda AP; Oliver C; Colom B
Rheumatol Int; 2018 Jul; 38(7):1293-1296. PubMed ID: 29417209
[TBL] [Abstract][Full Text] [Related]
33. Management of Myositis-Associated Interstitial Lung Disease.
Fujisawa T
Medicina (Kaunas); 2021 Apr; 57(4):. PubMed ID: 33916864
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
